VIRGINIA RETIREMENT SYSTEMS ET Al reduced its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 240,250 shares of the company's stock after selling 17,700 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al's holdings in Procter & Gamble were worth $34,904,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Parcion Private Wealth LLC boosted its holdings in Procter & Gamble by 7.9% in the 3rd quarter. Parcion Private Wealth LLC now owns 58,190 shares of the company's stock valued at $8,454,000 after purchasing an additional 4,245 shares during the period. Partners Wealth Management LLC increased its holdings in shares of Procter & Gamble by 93.9% in the third quarter. Partners Wealth Management LLC now owns 11,193 shares of the company's stock worth $1,626,000 after purchasing an additional 5,419 shares during the period. Soltis Investment Advisors LLC increased its holdings in shares of Procter & Gamble by 39.6% in the third quarter. Soltis Investment Advisors LLC now owns 89,378 shares of the company's stock worth $12,985,000 after purchasing an additional 25,339 shares during the period. Founders Financial Securities LLC raised its position in shares of Procter & Gamble by 3.0% in the third quarter. Founders Financial Securities LLC now owns 47,213 shares of the company's stock worth $6,859,000 after buying an additional 1,358 shares in the last quarter. Finally, Keeler & Nadler Financial Planning & Wealth Management purchased a new stake in shares of Procter & Gamble in the third quarter worth $207,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently commented on PG shares. Piper Sandler boosted their target price on Procter & Gamble from $145.00 to $167.00 and gave the stock a "neutral" rating in a research report on Monday. JPMorgan Chase & Co. raised their price target on Procter & Gamble from $162.00 to $180.00 and gave the company an "overweight" rating in a report on Friday, October 23rd. Sanford C. Bernstein reiterated a "market perform" rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Evercore raised Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective for the company in a report on Tuesday, October 6th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Procter & Gamble in a research report on Monday, September 21st. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $170.57.
Read Our Latest Stock Analysis on PG
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
- Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
- Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
- Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
- Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
- Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Paul Gama sold 4,331 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total value of $698,460.37. Following the completion of the sale, the chief executive officer owned 46,793 shares of the company's stock, valued at $7,546,307.11. This represents a 8.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 4,030 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the transaction, the insider directly owned 187,001 shares in the company, valued at $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 58,647 shares of company stock worth $9,268,508 in the last quarter. 0.23% of the stock is owned by company insiders.
Procter & Gamble Stock Performance
NYSE PG opened at $161.42 on Friday. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The company has a fifty day moving average of $149.99 and a 200-day moving average of $148.94. The company has a market capitalization of $374.14 billion, a P/E ratio of 24.31, a P/E/G ratio of 3.95 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion for the quarter, compared to analysts' expectations of $22.80 billion. During the same quarter in the prior year, the firm earned $1.99 earnings per share. The firm's revenue was up 4.0% on a year-over-year basis. As a group, equities research analysts predict that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio is 65.51%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.